Icon Bioscience Overview

  • Founded
  • 2004
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 13
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $1.68M
Latest Deal Amount

Icon Bioscience General Information

Description

Developer of a bio-pharma platform designed to deliver injectable ophthalmic drug-device combination therapeutics. The company's bio-pharma platform focuses on the development and commercialization of novel intraocular therapeutics based on proprietary and patented drug delivery platform, enabling the healthcare professionals to experience a transformational change in the delivery of ophthalmic pharmaceuticals and address the unmet or under-satisfied ophthalmic pharmaceutical needs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Therapeutic Devices
Primary Office
  • 39899 Balentine Drive
  • Suite 200
  • Newark, CA 94560
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Icon Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 28-Mar-2018 $1.68M 000.00 00.000 Completed Profitable
3. Later Stage VC 01-Dec-2015 00.000 000.00 Completed Profitable
2. Later Stage VC (Series B) 28-Aug-2013 $15M $32M 0000 Completed Clinical Trials - Phase 3
1. Early Stage VC 19-Sep-2007 $17M $17M 000.00 Completed Startup
To view Icon Bioscience’s complete valuation and funding history, request access »

Icon Bioscience Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series A 000,000 00.000000 00 000.00 000.00 00 000.00 00.000
To view Icon Bioscience’s complete cap table history, request access »

Icon Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a bio-pharma platform designed to deliver injectable ophthalmic drug-device combination therapeutics. The c
Biotechnology
Newark, CA
13 As of 2013
000.00
0.000 0000-00-00
000000&0 000.00

000000 0

tur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad m
0000 00000000
Bedford, MA
000 As of 0000
00000
00000000000 00000

0000000

tation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehender
000000000000000
Cambridge, MA
000 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Icon Bioscience Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ocular Therapeutix Formerly VC-backed Bedford, MA 000 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Cambridge, MA 000 000.00 000000000 000.00
0000 000000000000 Angel-Backed Austin, TX 00.000 0000000000 00.000
000000 000000000 Corporation Oxford, United Kingdom 000 00000 000000000 00000
0000000 000000 Venture Capital-Backed Redwood City, CA 00 00000 00000000 00000
To view Icon Bioscience’s complete competitors history, request access »

Icon Bioscience Executive Team (6)

Name Title Board Seat Contact Info
Howard Franklin MD Vice President, Clinical & Medical Affairs
Cathy Gerlett Vice President, Quality and Compliance
You’re viewing 2 of 6 executive team members. Get the full list »

Icon Bioscience Board Members (3)

Name Representing Role Since
Vernon Wong MD Icon Bioscience Chairman & Founder 000 0000
To view Icon Bioscience’s complete board members history, request access »

Icon Bioscience Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Icon Bioscience Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Signet Healthcare Partners Growth/Expansion Minority 000 0000 000000 0
To view Icon Bioscience’s complete investors history, request access »